HHS aims high in vax plan

The U.S. Department of Health and Human Services wants to surge manufacturing capacity for its vaccine programs. Pandemic influenza, emerging diseases and bioterrorism threats drive the need, according to the 2010 National Vaccine Plan.

The plan has two components: strategic objectives for the coming decade and an implementation plan. The objectives are supported by strategies.

Objective 1.2, for example, calls for research to develop and manufacture vaccines to prevent infectious diseases. It's supported by five strategies. One of them is development of "new approaches to vaccine manufacturing (e.g., rapid, flexible, and cost-effective)" that provide for expandable production during public health emergencies.

Another objective is the "timely integration" of manufacturing and regulatory advances that enhance product quality and patient safety. A related strategy involves developments to manufacturing sciences and quality systems, including "production technologies, in-process controls and testing, and identification of best practices in preventive quality systems and oversight."

- here's the plan


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.